Aaron Gregory Schmidt, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hemagglutinin Glycoproteins, Influenza Virus | 13 | 2024 | 158 | 3.450 |
Why?
|
Antibodies, Viral | 34 | 2024 | 3150 | 2.860 |
Why?
|
Antibodies, Neutralizing | 28 | 2024 | 1936 | 2.380 |
Why?
|
Influenza Vaccines | 12 | 2024 | 767 | 2.300 |
Why?
|
Epitopes | 10 | 2022 | 2501 | 1.590 |
Why?
|
Viral Envelope Proteins | 6 | 2022 | 640 | 1.570 |
Why?
|
Immunity, Humoral | 11 | 2024 | 600 | 1.430 |
Why?
|
Virus Internalization | 7 | 2022 | 497 | 1.250 |
Why?
|
B-Lymphocytes | 12 | 2024 | 4745 | 1.180 |
Why?
|
Germinal Center | 4 | 2023 | 380 | 1.100 |
Why?
|
Dengue Virus | 4 | 2016 | 201 | 1.070 |
Why?
|
Chiroptera | 1 | 2024 | 62 | 0.910 |
Why?
|
Zoonoses | 1 | 2024 | 179 | 0.870 |
Why?
|
Coronavirus | 2 | 2021 | 156 | 0.690 |
Why?
|
Influenza, Human | 6 | 2024 | 1518 | 0.680 |
Why?
|
Antibody Formation | 5 | 2024 | 1390 | 0.670 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2019 | 83 | 0.640 |
Why?
|
Virion | 6 | 2022 | 422 | 0.530 |
Why?
|
Binding Sites, Antibody | 2 | 2015 | 337 | 0.530 |
Why?
|
Influenza A virus | 6 | 2024 | 458 | 0.510 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2016 | 445 | 0.490 |
Why?
|
Antigen Presentation | 1 | 2020 | 1250 | 0.470 |
Why?
|
Orthomyxoviridae Infections | 3 | 2024 | 254 | 0.460 |
Why?
|
Receptors, Virus | 2 | 2020 | 639 | 0.420 |
Why?
|
Orthomyxoviridae | 2 | 2016 | 149 | 0.410 |
Why?
|
Polysaccharides | 1 | 2019 | 1013 | 0.410 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2022 | 82 | 0.400 |
Why?
|
Antiviral Agents | 3 | 2016 | 3039 | 0.360 |
Why?
|
Aedes | 2 | 2014 | 97 | 0.360 |
Why?
|
Biomimetic Materials | 1 | 2012 | 172 | 0.350 |
Why?
|
Coronavirus Infections | 8 | 2020 | 3088 | 0.330 |
Why?
|
Pneumonia, Viral | 8 | 2020 | 3209 | 0.330 |
Why?
|
Peptides | 2 | 2012 | 4354 | 0.320 |
Why?
|
Cross Reactions | 5 | 2021 | 816 | 0.320 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2020 | 363 | 0.310 |
Why?
|
Immunoglobulin G | 10 | 2023 | 4533 | 0.310 |
Why?
|
Protein Engineering | 2 | 2021 | 548 | 0.290 |
Why?
|
Dengue | 1 | 2010 | 254 | 0.290 |
Why?
|
Glycosylation | 2 | 2021 | 1098 | 0.280 |
Why?
|
Models, Molecular | 3 | 2017 | 5433 | 0.280 |
Why?
|
Animals | 31 | 2024 | 168201 | 0.280 |
Why?
|
HIV Antibodies | 3 | 2020 | 1302 | 0.270 |
Why?
|
Vaccination | 6 | 2024 | 3370 | 0.260 |
Why?
|
Mice, Inbred BALB C | 5 | 2022 | 6188 | 0.260 |
Why?
|
Immunologic Memory | 5 | 2021 | 1355 | 0.250 |
Why?
|
HEK293 Cells | 6 | 2022 | 4269 | 0.250 |
Why?
|
Immunoglobulin M | 5 | 2020 | 1526 | 0.250 |
Why?
|
Antigens, Viral | 2 | 2021 | 987 | 0.250 |
Why?
|
Mice | 19 | 2024 | 81368 | 0.250 |
Why?
|
Viral Vaccines | 2 | 2020 | 595 | 0.240 |
Why?
|
Macaca mulatta | 6 | 2021 | 2328 | 0.240 |
Why?
|
Fetal Blood | 2 | 2021 | 1347 | 0.230 |
Why?
|
Nucleocapsid Proteins | 2 | 2023 | 76 | 0.230 |
Why?
|
Vaccines, Virus-Like Particle | 1 | 2024 | 43 | 0.220 |
Why?
|
Crystallography, X-Ray | 3 | 2019 | 1989 | 0.210 |
Why?
|
Immunoglobulin A | 3 | 2020 | 978 | 0.210 |
Why?
|
Immunoassay | 3 | 2021 | 744 | 0.210 |
Why?
|
Immunoglobulin Variable Region | 2 | 2015 | 419 | 0.210 |
Why?
|
Amino Acid Sequence | 8 | 2020 | 13441 | 0.210 |
Why?
|
Nasal Mucosa | 3 | 2020 | 415 | 0.210 |
Why?
|
Aluminum Hydroxide | 1 | 2022 | 54 | 0.200 |
Why?
|
Protein Binding | 6 | 2023 | 9345 | 0.200 |
Why?
|
Immunodominant Epitopes | 2 | 2021 | 238 | 0.200 |
Why?
|
Rotavirus | 1 | 2022 | 109 | 0.190 |
Why?
|
Vimentin | 1 | 2022 | 255 | 0.190 |
Why?
|
Vaccines, Attenuated | 1 | 2022 | 315 | 0.190 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 2023 | 544 | 0.180 |
Why?
|
Receptors, IgG | 2 | 2021 | 558 | 0.180 |
Why?
|
Humans | 56 | 2024 | 760617 | 0.180 |
Why?
|
Pandemics | 10 | 2022 | 8645 | 0.180 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 111 | 0.180 |
Why?
|
Lymphocyte Activation | 2 | 2021 | 5463 | 0.170 |
Why?
|
Viral Load | 8 | 2021 | 3325 | 0.170 |
Why?
|
Extracellular Space | 1 | 2022 | 562 | 0.170 |
Why?
|
Antibodies | 3 | 2022 | 2414 | 0.170 |
Why?
|
Immunoglobulin Fab Fragments | 3 | 2022 | 445 | 0.170 |
Why?
|
Heparitin Sulfate | 1 | 2020 | 223 | 0.160 |
Why?
|
Adaptive Immunity | 1 | 2024 | 724 | 0.160 |
Why?
|
Capsid Proteins | 1 | 2022 | 464 | 0.160 |
Why?
|
Molecular Sequence Data | 6 | 2015 | 17629 | 0.160 |
Why?
|
Vaccines, Synthetic | 4 | 2022 | 612 | 0.160 |
Why?
|
Enterocytes | 1 | 2020 | 220 | 0.160 |
Why?
|
Vaccines, DNA | 1 | 2020 | 283 | 0.160 |
Why?
|
Binding Sites | 5 | 2023 | 6051 | 0.160 |
Why?
|
Cricetinae | 3 | 2024 | 2424 | 0.150 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2020 | 303 | 0.150 |
Why?
|
Autoantigens | 2 | 2019 | 888 | 0.150 |
Why?
|
Peptide Fragments | 1 | 2010 | 5110 | 0.150 |
Why?
|
Molecular Dynamics Simulation | 3 | 2020 | 437 | 0.140 |
Why?
|
Immunization | 1 | 2021 | 1217 | 0.140 |
Why?
|
AIDS Vaccines | 1 | 2023 | 896 | 0.140 |
Why?
|
Goblet Cells | 1 | 2020 | 298 | 0.140 |
Why?
|
Immunization, Passive | 1 | 2019 | 616 | 0.140 |
Why?
|
Cysteine | 1 | 2021 | 891 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 486 | 0.140 |
Why?
|
Sialic Acids | 1 | 2016 | 123 | 0.140 |
Why?
|
Protein Conformation | 3 | 2022 | 3965 | 0.130 |
Why?
|
Adenoviridae | 1 | 2020 | 1084 | 0.130 |
Why?
|
Interferon Type I | 1 | 2020 | 557 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2024 | 1009 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2016 | 140 | 0.130 |
Why?
|
Vaccines | 1 | 2024 | 838 | 0.120 |
Why?
|
HIV Infections | 6 | 2023 | 17337 | 0.120 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2020 | 974 | 0.120 |
Why?
|
Complementarity Determining Regions | 1 | 2015 | 149 | 0.120 |
Why?
|
HIV-1 | 4 | 2020 | 6858 | 0.120 |
Why?
|
Recombinant Proteins | 2 | 2021 | 6520 | 0.120 |
Why?
|
Cell Line | 7 | 2020 | 15576 | 0.120 |
Why?
|
West Nile virus | 1 | 2014 | 77 | 0.120 |
Why?
|
Molecular Mimicry | 1 | 2015 | 213 | 0.110 |
Why?
|
Bronchoalveolar Lavage Fluid | 3 | 2021 | 755 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1351 | 0.110 |
Why?
|
Membrane Fusion | 1 | 2014 | 266 | 0.110 |
Why?
|
Mutation | 6 | 2021 | 30016 | 0.100 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2015 | 647 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1213 | 0.100 |
Why?
|
Placenta | 1 | 2020 | 1709 | 0.090 |
Why?
|
Seroepidemiologic Studies | 2 | 2023 | 397 | 0.090 |
Why?
|
Immunity, Cellular | 3 | 2020 | 1550 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2023 | 3800 | 0.090 |
Why?
|
Serotyping | 1 | 2010 | 325 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2019 | 2299 | 0.090 |
Why?
|
Survival Analysis | 2 | 2020 | 10073 | 0.090 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2014 | 914 | 0.080 |
Why?
|
Capsid | 2 | 2013 | 433 | 0.080 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 398 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2022 | 3548 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2149 | 0.080 |
Why?
|
Peptide Library | 2 | 2021 | 347 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22115 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4366 | 0.070 |
Why?
|
Simian immunodeficiency virus | 1 | 2013 | 810 | 0.070 |
Why?
|
Protein Structure, Tertiary | 4 | 2016 | 3792 | 0.070 |
Why?
|
Hemagglutinins, Viral | 2 | 2018 | 66 | 0.070 |
Why?
|
Female | 21 | 2022 | 392148 | 0.070 |
Why?
|
Biological Evolution | 1 | 2013 | 1070 | 0.070 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 206 | 0.070 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 2152 | 0.070 |
Why?
|
Antigens | 2 | 2022 | 1441 | 0.070 |
Why?
|
HLA-B Antigens | 1 | 2007 | 317 | 0.070 |
Why?
|
Cryoelectron Microscopy | 2 | 2022 | 650 | 0.060 |
Why?
|
Virus Replication | 3 | 2021 | 2427 | 0.060 |
Why?
|
Serine Endopeptidases | 2 | 2020 | 1022 | 0.060 |
Why?
|
Male | 19 | 2022 | 360358 | 0.060 |
Why?
|
Evolution, Molecular | 1 | 2012 | 1880 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2018 | 9172 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 3027 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2020 | 18937 | 0.060 |
Why?
|
Pan troglodytes | 1 | 2024 | 223 | 0.050 |
Why?
|
Antibodies, Blocking | 1 | 2024 | 243 | 0.050 |
Why?
|
Dogs | 2 | 2019 | 3838 | 0.050 |
Why?
|
Serial Passage | 1 | 2022 | 23 | 0.050 |
Why?
|
Hemagglutinins | 1 | 2023 | 111 | 0.050 |
Why?
|
HIV Antigens | 1 | 2023 | 325 | 0.050 |
Why?
|
Protein Structure, Quaternary | 2 | 2014 | 428 | 0.050 |
Why?
|
Coronavirus OC43, Human | 1 | 2021 | 18 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2023 | 14648 | 0.050 |
Why?
|
Lung | 4 | 2021 | 9998 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2020 | 2446 | 0.050 |
Why?
|
Protein Structure, Secondary | 2 | 2014 | 1229 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18221 | 0.050 |
Why?
|
Haplorhini | 1 | 2021 | 525 | 0.040 |
Why?
|
Mesocricetus | 1 | 2020 | 252 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2007 | 1779 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2020 | 364 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 191 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5672 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2024 | 1739 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 901 | 0.040 |
Why?
|
Adult | 10 | 2022 | 220969 | 0.040 |
Why?
|
Antigen-Antibody Reactions | 1 | 2019 | 340 | 0.040 |
Why?
|
Lactation | 1 | 2021 | 397 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2020 | 1058 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15828 | 0.040 |
Why?
|
Cohort Studies | 4 | 2022 | 41457 | 0.040 |
Why?
|
Mutant Proteins | 1 | 2020 | 489 | 0.040 |
Why?
|
Proteins | 1 | 2013 | 6030 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2022 | 1336 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2021 | 534 | 0.040 |
Why?
|
Transgenes | 1 | 2021 | 1008 | 0.040 |
Why?
|
Interferometry | 1 | 2018 | 100 | 0.040 |
Why?
|
Middle Aged | 9 | 2021 | 220584 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8833 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2020 | 368 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2019 | 399 | 0.040 |
Why?
|
Kinetics | 2 | 2015 | 6370 | 0.040 |
Why?
|
Single-Chain Antibodies | 1 | 2017 | 111 | 0.030 |
Why?
|
Influenza in Birds | 1 | 2016 | 76 | 0.030 |
Why?
|
Antibody Diversity | 1 | 2016 | 72 | 0.030 |
Why?
|
Dependovirus | 1 | 2021 | 712 | 0.030 |
Why?
|
Cytokines | 2 | 2021 | 7373 | 0.030 |
Why?
|
Crystallization | 1 | 2016 | 533 | 0.030 |
Why?
|
Eggs | 1 | 2016 | 182 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2016 | 246 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2020 | 990 | 0.030 |
Why?
|
Chickens | 1 | 2016 | 858 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2016 | 669 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1835 | 0.030 |
Why?
|
Spleen | 1 | 2020 | 2286 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1700 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10175 | 0.030 |
Why?
|
Plasma Cells | 1 | 2016 | 597 | 0.030 |
Why?
|
Heparin | 1 | 2020 | 1632 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3575 | 0.030 |
Why?
|
Protein Stability | 1 | 2015 | 578 | 0.030 |
Why?
|
Models, Chemical | 1 | 2014 | 611 | 0.030 |
Why?
|
RNA, Viral | 1 | 2020 | 2838 | 0.020 |
Why?
|
Cats | 1 | 2013 | 975 | 0.020 |
Why?
|
Molecular Structure | 1 | 2016 | 1878 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1692 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 918 | 0.020 |
Why?
|
Aged | 5 | 2022 | 169042 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1350 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6338 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58894 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4117 | 0.020 |
Why?
|
Survivors | 1 | 2021 | 2372 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2023 | 9529 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2020 | 3392 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3074 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2021 | 2674 | 0.020 |
Why?
|
Antigens, Bacterial | 1 | 2016 | 1141 | 0.020 |
Why?
|
Bacterial Toxins | 1 | 2016 | 925 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1662 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4571 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7196 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2014 | 2495 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 59179 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2022 | 4433 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1936 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2014 | 982 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 29868 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4341 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1914 | 0.020 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2013 | 541 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2447 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 88234 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8426 | 0.020 |
Why?
|
Cyclophilin A | 1 | 2007 | 58 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2018 | 5863 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12043 | 0.020 |
Why?
|
Tuberculosis | 1 | 2020 | 2015 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3877 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54360 | 0.020 |
Why?
|
Rats | 1 | 2022 | 23717 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10505 | 0.020 |
Why?
|
HIV | 1 | 2013 | 1579 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3634 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7045 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12334 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13495 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10754 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 1894 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22148 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2014 | 3672 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 4242 | 0.010 |
Why?
|
Drug Resistance, Viral | 1 | 2007 | 861 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6861 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7568 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26049 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6233 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26180 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64568 | 0.010 |
Why?
|
Child | 1 | 2020 | 80079 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 80566 | 0.010 |
Why?
|